secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVIVO THERAPEUTICS HOLDINGS CORP. (—)
CIK:        0001292519
Form:       8-K
Filed at:   2024-02-06T23:59:59+00:00
Accession:  0001104659-24-010941
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

InVivo Therapeutics receives Nasdaq delisting notice after Chapter 11 filing; trading to suspend Feb 13
--------------------------------------------------------------------------------

- Filed Chapter 11 bankruptcy on Feb 1, 2024.
- Nasdaq notified company of delisting on Feb 2, 2024, per Listing Rules 5101, 5110(b), IM-5101-1.
- Company will not appeal; common stock to be suspended at opening of business on Feb 13, 2024.
- Form 25-NSE will be filed removing securities from Nasdaq listing and registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1292519/000110465924010941/0001104659-24-010941-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1292519/000110465924010941/tm245285d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-010941

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer